Oral Versus Intravenous Antibiotic Prophylaxis Before Obstetric and Gynecological Procedures

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06255652

Enrollment

Registered

2024-02-13

Start date

2023-10-01

Completion date

2024-07-31

Last updated

2024-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Site Infection

Keywords

SSI

Brief summary

Oral versus intravenous antimicrobial prophylaxis for the prevention of surgical site infection for elective cesarean section and gynacological procedures

Detailed description

the aim of the current study is to compare the efficacy of prophylactic intravenous (cephradine) and oral antibiotic (cephradine) for the prevention of surgical site infection in the elective obctetric and gynecological procedures

Interventions

DRUGCephradin

Velosef

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 50 Years

Healthy volunteers

Inclusion criteria

\- Cesarean section Gynaecological procedure

Exclusion criteria

Immunocompromised patient \-

Design outcomes

Primary

Measure	Time frame	Description
proportion of patients with any SSI within 30 days after surgery	July 2024	July 2024

Countries

Egypt

Contacts

Primary Contactyasmeen YT Tharwat, Resident

yassmintharwat@med.sohag.edu.eg01289986222

Backup ContactAbdou a SAeed, Professor

01008385445

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026